logo
Plus   Neg
Share
Email

Pharma News Today (TRVN,FPRX,TTPH)

Trevena, Inc. (TRVN) on Tuesday announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for OLINVO (oliceridine), a moderate to severe acute pain reliever injection. The Company expects that the PDUFA date for the NDA will be in the fourth quarter of 2018.

Five Prime Therapeutics, Inc. (FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, announced that on December 27, 2017, the company initiated dosing in the Phase 1 portion of the FIGHT Phase 1/3 clinical trial of FPA144, an isoform-selective anti-FGF receptor 2b antibody, in combination with chemotherapy in patients with previously untreated, advanced gastric or gastroesophageal cancer.

Tetraphase Pharmaceuticals, Inc. (TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- resistant infections, announced that it has submitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for intravenous eravacycline for the treatment of complicated intra-abdominal infections.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Philip Morris International Inc. has launched a new advertising campaign in the UK that encourages people to stop smoking. However, the tobacco giant has been accused by anti-smoking campaigners of hypocrisy and cynicism for the move. The maker of Marlboro cigarettes announced earlier in 2018 that it intends to eventually stop selling cigarettes in the UK. Kimberly-Clark Corp. (KMB) reported third-quarter adjusted earnings per share of $1.71, an increase of 7 percent compared to net income per share of $1.60, prior year. On average, 16 analysts polled by Thomson Reuters expected the company to report profit per share of $1.64 for the quarter. Analysts'... South Korean IT services company Samsung SDS has joined with Dutch bank ABN AMRO and Port of Rotterdam Authority for a trial project that applies blockchain to shipping and logistics business. Samsung SDS, the IT arm of South Korean Conglomerate Samsung, and ABN AMRO will connect their blockchain platforms Nexledger and Corda, respectively, with the pilot.
Follow RTT